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The current standard of treatment against tuber-
culosis consists of a cocktail of first-line drugs,
including isoniazid and pyrazinamide. Although
these drugs are known to be bactericidal, contribu-
tion of host cell responses in the context of antimyco-
bacterial chemotherapy, if any, remains unknown.
We demonstrate that isoniazid and pyrazinamide
promote autophagy activation and phagosomal
maturation in Mycobacterium tuberculosis (Mtb)-
infected host cells. Treatment of Mtb-infected
macrophages with isoniazid or pyrazinamide caused
significant activation of cellular and mitochondrial
reactive oxygen species and autophagy, which was
triggered by bacterial hydroxyl radical generation.
Mycobacterium marinum-infected autophagy-
defective, atg7 mutant Drosophila exhibited
decreased survival rates, which could not be rescued
by antimycobacterial treatment, indicating that
autophagy is required for effective antimycobacterial
drug action in vivo. Moreover, activation of auto-
phagy by antibiotic treatment dampened Mtb-
induced proinflammatory responses in macro-
phages. Together, these findings underscore the
importance of host autophagy in orchestrating
successful antimicrobial responses to mycobacteria
during chemotherapy.Cell HINTRODUCTION
Tuberculosis (TB) remains a major public health problem world-
wide (WHO, 2009). In developing countries, TB remains highly
endemic, and the incidence is increasing as a consequence of
the HIV epidemic (WHO, 2009). TB is one of the leading causes
of death from an infectious agent, with approximately twomillion
deaths annually (WHO, 2009). Antibiotic treatments for newly
diagnosed cases of pulmonary and extrapulmonary TB generally
include a cocktail of first-line drugs, including isoniazid (INH),
rifampin, pyrazinamide (PZA), and ethambutol, for 6 months
(Lienhardt et al., 2011). Currently, anti-TB chemotherapy is
encountering numerous challenges, including coinfection with
HIV, adherence issues, and the emergence of multi-drug-resis-
tant strains of Mycobacterium tuberculosis (Mtb) (WHO, 2009;
Russell et al., 2010). Thus, the discovery of drugs, identification
of targets, and development of fast-acting medications against
human TB have become primary concerns. However, the
majority of target-based discovery programs are unlikely to be
effective. Understanding the host response and micro-
environment of Mtb-infected macrophages may assist in the
development of more effective treatments against intracellular
Mtb infection and provide additional strategies for chemothera-
peutic intervention.
Autophagy is an essential intracellular quality and quantity
control process that delivers cytoplasmic constituents for lyso-
somal degradation (Yoshimori and Noda, 2008). Recent studies
have shown that autophagy facilitates host defenses against
intracellular pathogens and connects the innate and adaptiveost & Microbe 11, 457–468, May 17, 2012 ª2012 Elsevier Inc. 457
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Antibiotics-Induced Autophagy against Mycobacteriaimmune functions (Deretic, 2010; Jo, 2010). Also, autophagy
may function as an innate effector against mycobacterial
infection through pattern-recognition receptor-dependent and
receptor-independent mechanisms (Yuk et al., 2009; Shin
et al., 2010a; Jo, 2010; Fabri et al., 2011; Deretic, 2010). Although
modern chemotherapy focuses on the development of additional
targets or modified drug actions to combat Mtb, the host
response during antibiotic treatment against Mtb infection
remains unknown. In this study, we show that antimycobacterial
antibiotic treatment robustly activates autophagy in host cells
infected with Mtb. When Mtb-infected macrophages were
treated with antimycobacterial antibiotics (INH or PZA), there
was a significant activation of cellular and mitochondrial reactive
oxygen species (ROS). NADPH oxidase (NOX) 2 deficiency and
mitochondrial ROS scavenger treatment significantly reduced
host cell autophagy. Notably, autophagy-defective (atg7mutant)
flies exhibited decreased survival, and antibiotic treatment
could not completely restore survival in a Drosophila model of
M. marinum (Mm) infection. Furthermore, host cell autophagy
orchestrated antimycobacterial activities and regulated inflam-
matory cytokine production in macrophages.
RESULTS
INH Treatment Activates Autophagy in Macrophages
Infected with Mtb
To determine whether INH treatment induces autophagy in vitro,
we infected primary murine bone marrow-derived macrophages
(BMDMs) with Mtb and cultured them in the presence and
absence of INH. Autophagosome accumulation was monitored
using microtubule-associated protein light-chain 3 (LC3) immu-
nofluorescence staining and detection. As shown in Figure 1A
and Figure S1A (online), INH treatment of Mtb-infected BMDMs
significantly increased the formation of endogenous LC3 punc-
tate structures, with a peak at 24 hr and a substantial decrease
by 48 hr. The autophagosomal membrane-associated fraction
of LC3-II was detected by flow cytometric analysis (Kaminskyy
et al., 2011). The mean fluorescence intensity level of LC3B-
expressing cells by flow cytometric analysis using anti-LC3B-
specific antibody was significantly correlated with LC3-II protein
level (data not shown). The autophagosomal membrane-associ-
ated LC3B and LC3-II fractions were detected by flow cytomet-
ric analysis and immunoblotting, respectively. Endogenous
LC3-II and LC3B protein levels were significantly greater in
Mtb-infected BMDMs cultured in INH-containing medium, but
not in Mtb-infected cells or those treated with INH alone (Figures
1B and 1C, LC3B and LC3-II, respectively).
The INH-induced formation of LC3 punctate foci in Mtb-in-
fected BMDMs was significantly abrogated after 2 hr of treat-
ment with 3-methyladenine (3-MA), an inhibitor of autophagy
(Blommaart et al., 1997) (Figure 1D). Furthermore, confocal
microscopic analysis confirmed that INH treatment induced
colocalization between LC3 autophagosomes and lysosomes
(Figure S1B). LC3 autophagosome formation was significantly
increased by pretreatment with the vacuolar H+-ATPase inhibitor
bafilomycin A1 (Baf-A) (Kabeya et al., 2000; Mizushima et al.,
2001) and chloroquine (Chq) (Amaravadi et al., 2007) (Figure 1D,
Figure S1C), suggesting that INH treatment induces autophagic
flux in Mtb-infected BMDMs. Notably, INH treatment of Mtb-in-458 Cell Host & Microbe 11, 457–468, May 17, 2012 ª2012 Elsevier Ifected BMDMs resulted in colocalization of the autophagosomal
marker LC3 and the bacterial phagosome (Figure 1E). Moreover,
ultrastructural analysis of Mtb-infected BMDMs treated with
INH for 24 hr revealed bacilli within characteristic double-
membrane autophagosomes (early autophagosomes) and
single-membrane vesicles containing degradative components
(late autophagosome; autophagolysosome) (Figure 1F). These
data indicate that INH treatment induces autophagy activation
and LC3 colocalization with bacterial phagosome in macro-
phages infected with Mtb.
Antibiotic Treatment of Macrophages at Antimicrobial
Doses against Mtb Induces Autophagy
We next questioned whether antibiotic treatment of Mtb-
infected macrophages at antimicrobial doses would induce
autophagy. To investigate this, we determined the effect of
increasing INH or PZA concentrations on intracellular antimicro-
bial activity and autophagy induction in Mtb-infected BMDMs.
As shown in Figures 2A and 2B, antibiotics at doses with
significant antimicrobial activities (0.1–0.5 mg/ml for INH;
10–20 mg/ml for PZA) actively induced autophagosome forma-
tion in Mtb-infected BMDMs. Similar to INH, PZA treatment led
to colocalization of the autophagosomal marker LC3 and the
bacterial phagosome in Mtb-infected BMDMs (Figure S2).
TheMtb catalase-peroxidase (KatG) enzyme is responsible for
activating the conversion of prodrug INH into the INH-NADH
adduct (Vilche`ze and Jacobs, 2007), a potent inhibitor of mycolic
acid biosynthesis and a component of the mycobacterial cell
wall (Rozwarski et al., 1998). PZA is also a prodrug that requires
conversion into its active form, pyrazinoic acid, bymycobacterial
pyrazinamidase (Zhang and Mitchison, 2003). We further deter-
mined whether active drugs converted bymycobacteria induced
autophagosome formation in macrophages treated with antibi-
otics. It is important to point out that neither clinical isolates of
INH-resistant katG mutant (K12006 and K12046) nor PZA-resis-
tant pncA mutant strains (MP13001 and MP13005) showed any
significant induction of autophagy, as determined by LC3 stain-
ing (Figures 2C and 2D). Moreover, treatment of Mtb-infected
BMDMs with a bacteriostatic drug such as chloramphenicol
(CAM) or tetracycline (Tet) did not increase autophagosome
formation (Figure 2E). These results suggest that treatment of
macrophages with active antimycobacterial drugs produced
by bacteria, at antimicrobial doses, leads to the activation of au-
tophagy during intracellular Mtb infection. These results suggest
that treatment of macrophages with antimycobacterial drugs
that are metabolized into the active form by bacteria, at antimi-
crobial doses, leads to the activation of autophagy during
intracellular Mtb infection.
Cellular and Mitochondrial ROS Generation Is Required
for INH-Induced Autophagy Activation in Mtb-Infected
Macrophages
NOX-derived ROS are involved in LC3 recruitment to phago-
somes and the regulation of autophagy (Huang et al., 2009). To
determine whether cellular and mitochondrial ROS are required
for antibiotic-mediated autophagy activation, ROS generation
was monitored in Mtb-infected BMDMs during incubation in
antibiotic-containing medium. Cellular and mitochondrial ROS
generation significantly increased in Mtb-infected BMDMs afternc.
Figure 1. INH Induces Autophagy in BMDMs Infected with Mtb
(A and B) BMDMs were infected with Mtb (moi = 10) for 2 hr, incubated with or without INH (0.5 mg/ml) for 24 hr, fixed with 4% paraformaldehyde, and im-
munolabeled with anti-LC3 (A) or anti-LC3B (B) Ab, followed by addition of Alexa 488-conjugated goat anti-rabbit IgG (green). Cells were stained with DAPI to
visualize the nuclei (blue, A) and then analyzed for LC3 by LSM 710 laser-scanning confocal microscopy (A) or by flow cytometry (B; for LC3B). (A) (Top)
Representative immunofluorescence images of seven independent replicates. Scale bar, 5 mm. (Bottom) Quantitative analysis of the LC3+ punctate foci per cell.
(B) (Top) Representative histogram of seven independent replicates. (Bottom) Quantification of LC3B. Data are presented as the average mean fluorescence
intensities (MFI).
(C) The experimental conditions were as outlined in (A). Cells were harvested and subjected to western blot analysis for LC3I/II and for b-actin as a loading control.
(D) BMDMswere infectedwithMtb (moi = 10) for 2 hr, followed by treatment with or without 3-MA (10 mM; 2 hr) or Baf-A (100 nM; 1 hr), and then incubatedwith INH
(0.5 mg/ml) for 24 hr. Induction of autophagy was assessed as described for (A).
(E) BMDMswere infected withMtb-ERFP (moi = 10) for 2 hr, incubated with or without INH (0.5 mg/ml) for 24 hr, fixed with 4%paraformaldehyde, and stained with
Alexa 488-conjugated LC3 Ab to detect autophagosomes (green) and DAPI to visualize the nuclei (blue). (Top) Representative immunofluorescence images of five
independent replicates are shown. Scale bar, 5 mm. (Bottom) Quantitative data of colocalization analyses showing the means ±SD of four independent
experiments, with each experiment including at least 200 internalized mycobacteria scored in seven random fields.
(F) BMDMs were infected with Mtb for 2 hr, treated with INH (0.5 mg/ml) for 24 hr, and subjected to transmission electron microscopy (TEM) analysis. (Top)
Representative TEM images from three independent experiments are shown. (Bottom) Quantitation of 200 internalized mycobacteria per experimental condition
(means ±SD).
Data are from one representative of at least three independent experiments (means ±SD of triplicate samples). *p < 0.05, **p < 0.01, ***p < 0.001 (two-tailed
Student’s t test). UI, uninfected. See also Figure S1.
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Antibiotics-Induced Autophagy against Mycobacteriatreatment with antimycobacterial antibiotics (Figure 3A for INH;
Figure S3A for PZA). The ROS scavengers N-acetyl cysteine
(NAC) and 4,5-dihydroxy-1,3-benzene disulfonic acid (tiron),
and the NOX inhibitor diphenylene iodonium (DPI), but not the
xanthine oxidase inhibitor allopurinol, reduced antibiotic-Cell Hinduced LC3-II protein accumulation, as shown by flow cytomet-
ric analysis and immunoblotting (Figures 3B and 3C and
Figure S3B). Thus, cellular ROS are required for INH- or PZA-
induced activation of autophagy. LC3-II protein analysis in
wild-type (WT) and NOX2-knockout (KO) BMDMs furtherost & Microbe 11, 457–468, May 17, 2012 ª2012 Elsevier Inc. 459
Figure 2. Antibiotic-Induced Autophagy Is Associated with Antimicrobial Activity in Mtb-Infected BMDMs
(A, B, and E) BMDMs were infected with Mtb (moi = 10) and incubated with INH (A) or PZA (B) at the indicated concentrations, (E) INH (0.5 mg/ml), PZA (20 mg/ml),
chloramphenicol (CAM; 10 mg/ml), or tetracycline (Tet; 10 mg/ml) for 24 hr. Cells were analyzed for LC3B immunofluorescence by flow cytometry at 24 hr (A and B,
left; E) or by CFU assay at 0 and 3 days (A and B, right). (A and B, left; E) The cells were immunolabeled with anti-LC3B Ab, followed by the addition of Alexa 488-
conjugated goat anti-rabbit IgG (green). (A and B, right) CFU data are the means ±SD of four individual experiments. (C and D) BMDMs were infected with two
INH-resistant Mtbs possessing a katGmutation (K12006 and K12046; for C) and two PZA-resistantMtb possessing a pncAmutation (MP13001 andMP13005; for
D) (moi = 10) for 2 hr and incubated with or without antibiotics (C, INH 0.5 mg/ml; D, PZA 20 mg/ml) for 24 hr. The cells were then fixed with 4% paraformaldehyde
and immunolabeled with anti-LC3 Ab, followed by the addition of Alexa 488-conjugated goat anti-rabbit IgG. The number of LC3 punctate dots per cell was
determined by confocal microscopic analysis. Data are from one representative of at least three independent experiments (means ±SD of triplicate samples). *p <
0.05, **p < 0.01, ***p < 0.001 (A, left; B, left; versus the Mtb-infected condition). UI, uninfected; PBS, PBS-treated. See also Figure S2.
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Antibiotics-Induced Autophagy against Mycobacteriashowed that NOX2 is required for induction of autophagy upon
antibiotic treatment after Mtb infection (Figure 3D). An ROS
scavenger specific to mitochondrial ROS (mito-TEMPO), which
effectively reduces mitochondrial ROS levels (Nakahira et al.,
2011), significantly reduced INH-induced autophagy activation
in Mtb-infected BMDMs (Figure 3E). Additionally, INH-resistant
katG mutant (K12006) and PZA-resistant pncA mutant
(MP13001) strains did not show increased ROS generation in
antibiotics-treated, each-strain-infected BMDMs, as determined
by dihydroethidium (DHE) staining (Figure 3F). This suggests that
both cellular and mitochondrial ROS are involved in antibiotic-
induced autophagy activation in Mtb-infected macrophages
and that host NOX2 activity is necessary.
Oxidative Stress in Bacteria Initiates Autophagy in
Mtb-Infected Macrophages after Antibiotic Treatment
Bactericidal drugs induce bacterial cell death through harmful
hydroxyl radical formation (Kohanski et al., 2007). We examined
whether bacteria-derived hydroxyl radicals could directly induce
autophagy activation in host macrophages. Mycobacterial
cultures were treated with INH for 24 hr, and the supernatants
from bacteria killed by INH (BKS-INH) were prepared as
described in the Supplemental Information. Autophagosome
formation significantly increased in BMDMs after treatment
with BKS-INH (1% v/v; Figure 4A). Additionally, BKS after PBS
treatment did not activate autophagosome formation in BMDMs
(Figure 4A), suggesting that a specific bacteria-derived factor(s)460 Cell Host & Microbe 11, 457–468, May 17, 2012 ª2012 Elsevier Ireleased after treatment with antimycobacterial antibiotics can
directly induce host cell autophagy. BKS prepared from
mycobacterial cultures after PZA treatment, but not after CAM
treatment, significantly increased LC3-positive autophagosome
formation in BMDMs (Figure S4A).
Next, we measured bacterial hydroxyl radicals in antibiotic-
treated bacterial cells at different time points. A biphasic pattern
of ROS generation was observed in bacterial cells treated with
INH (Figure 4B), with peak activation at 1 hr. A substantially
elevated ROS level was also detected in bacterial cells treated
with PZA (Figure S4B). Using hydroxyphenyl fluorescein (HPF),
a fluorescent indicator for detection of hydroxyl radicals (Kohan-
ski et al., 2007), a similar biphasic pattern of hydroxyl radical
generation was observed in bacterial cells treated with INH (Fig-
ure 4C) and PZA (Figure S4C). Blocking bacterial hydroxyl radical
generation with the antioxidant 1,3-dimethyl-2-thiourea (thio-
urea) or the iron chelator deferoxamine (DFO) significantly
decreased autophagy induction in BMDMs after treatment with
BKS-INH (Figure 4D).
The observation that BKS-INH and BKS-PZA directly acti-
vated host cell autophagy led us to consider that BKS-INH
may modulate cellular and mitochondrial ROS in macrophages.
BKS-INH significantly elevated cellular andmitochondrial ROS in
BMDMs (Figure 4E), whereas BKS after bacteriostatic drug treat-
ment did not (data not shown). Additionally, the generation of
ROS was responsible for activating autophagy, as ROS scaven-
gers significantly reduced LC3 autophagosome formation innc.
Figure 3. Treatment of Mtb-Infected
BMDMs with INH Increases Cellular and
Mitochondrial ROS, Leading to Autophagy
Activation
(A) BMDMs were infected with Mtb (moi = 10) for
2 hr and incubated with or without INH (0.5 mg/ml)
for 30min. The cells were then incubated with DHE
(10 mM), DCFH-DA (10 mM), or MitoSOX (10 mM) for
30 min; washed thoroughly; and immediately
analyzed by flow cytometry for superoxide, H2O2,
or mitochondrial ROS production. (Left) Repre-
sentative histogram. (Right) Data are presented as
the average MFI.
(B and C) BMDMs were infected with Mtb (moi =
10; 2 hr), followed by treatment with 3-MA (3MA,
10 mM; 2 hr), NAC (5, 10, 20 mM; 1 hr), DPI (5, 10,
20 mM; 1 hr), tiron (5, 10 mM; 1 hr), or allopurinol
(Allo, 0.01, 0.1, 1 mM; 1 hr), and then incubated
with INH (0.5 mg/ml) for 24 hr. (B) Quantification of
LC3B by flow cytometry. Data are presented as
the average MFI. (C) Western blotting for LC3 I/II
and b-actin as a loading control. The ratio of the
intensities of the LC3-II and LC3-I bands is indi-
cated below each lane.
(D and E) Induction of autophagy was assessed
as described in Figure 1B. (D) BMDMs from
NOX2 WT or KO mice were infected with Mtb
(moi = 10) for 2 hr and incubated with or
without INH (0.5 mg/ml) or PZA (20 mg/ml) for
24 hr. (E) BMDMs were infected with Mtb (moi =
10) for 2 hr, followed by treatment with or without
mito-TEMPO (500 mM, 1 hr) and then in-
cubated with INH (0.5 mg/ml) for 24 hr. (Left) A
representative histogram of seven independent
replicates is shown; (D and E, right) quantification of LC3B by flow cytometry (data are presented as the average MFI).
(F) BMDMswere infected with INH-resistant Mtb possessing a katGmutation (K12006) and PZA-resistant Mtb possessing a pncAmutation (MP13001) (moi = 10)
for 2 hr, and incubated with or without antibiotics (INH, 0.5 mg/ml; PZA, 20 mg/ml) for 30 min. Then the cells were incubated with DHE (10 mM) for 30 min and
washed thoroughly, and superoxide production was immediately assayed by flow cytometry. Data are presented as the average MFI.
Data are from one representative of at least three independent experiments (means ±SD of triplicate [A, right; B, D, and E, right; F] samples). *p < 0.05, **p < 0.01,
***p < 0.001 (two-tailed Student’s t test; B, versus SC). UI, uninfected. See also Figure S3.
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Antibiotics-Induced Autophagy against MycobacteriaBMDMs in response to BKS-INH (Figure 4F) or BKS-PZA
(Figure S4D). Moreover, NOX2 was required for BKS-INH- or
BKS-PZA-induced autophagy activation in BMDMs (Figure 4G).
These results suggest that bacterial ROS formation induced by
antimycobacterial drug treatment contributes to autophagy acti-
vation by generating cellular andmitochondrial ROS in host cells.
Intracellular Calcium and AMPK Pathway Activation Are
Involved in Autophagy Induction in Mtb-Infected
Macrophages after Antibiotic Treatment
Ca2+-dependent autophagy is induced by 50-adenosine
monophosphate-activated protein kinase (AMPK) activation
(Hoyer-Hansen and Ja¨a¨ttela¨, 2007). Thus, we examined whether
treatment of BMDMs with antimycobacterial drugs would result
in a significant increase in intracellular Ca2+ release. The intracel-
lular calcium concentration estimated in Mtb-infected BMDMs
loaded with the indicator fluo-4AM increased after 3 min of treat-
ment with both INH and PZA (Figure 5A). This rapid increase in
intracellular calcium was not detected in Mtb-infected BMDMs
in response to the bacteriostatic drugs CAM or Tet (Figure 5A).
Notably, treatment of noninfected BMDMs with BKS-INH signif-
icantly induced intracellular calcium influx, based on Fura-2
signals (Figure 5B).Cell HWe further examined whether an intracellular calcium increase
and the AMPK pathway are required for antibiotic-induced
autophagy activation in Mtb-infected BMDMs. As shown in
Figure 5C, the INH-induced increase in endogenous LC3 punc-
tate foci was significantly reduced in Mtb-infected BMDMs
after treatment with the calcium chelator BAPTA/AM or an
ATP-competitive inhibitor of AMPK (Compound C). The
shRNA-mediated knockdown of AMPK also significantly attenu-
ated INH- and PZA-induced LC3 punctate formation, respec-
tively, in Mtb-infected BMDMs (Figure 5D), corroborating the
results with pharmacological inhibitors. Moreover, the increased
autophagy induced by BKS-INH or BKS-PZA was significantly
inhibited in BMDMs transduced with specific shRNA against
AMPK (Figure 5E). This suggests that intracellular calcium and
the AMPK pathway are required for antibiotic-induced autoph-
agy activation in BMDMs infected with Mtb.
Host Cell Autophagy Activation Is Essential for
Antimycobacterial Drug Action in Mtb-Infected
Macrophages and Mm-Infected Flies
Next, we explored whether host cell autophagy activation
contributes to antibiotic-mediated antimicrobial responses
during intracellular Mtb infection. Treatment of BMDMs withost & Microbe 11, 457–468, May 17, 2012 ª2012 Elsevier Inc. 461
Figure 4. Bacterial Supernatants Prepared fromAntibiotic-TreatedMycobacterial Cultures Directly Induce Autophagy inUninfected BMDMs
through Induction of ROS
(A) BMDMs were incubated with BKS-INH (1% v/v) or PBS for 24 hr. The BMDMs were fixed and immunolabeled with anti-LC3 Ab, followed by the addition of
Alexa 488-conjugated goat anti-rabbit IgG (green), and stainedwith DAPI to visualize the nuclei (blue). (Top) Representative immunofluorescence images of seven
independent replicates. Scale bar, 5 mm. (Bottom) Quantitative analysis of LC3+ punctate foci per cell. (B and C) Mtb were incubated with or without INH for the
indicated times and stained by DCFH-DA (B, 10 mM) or HPF (C, 5 mM) for 30min, and then ROS levels were assayed using a fluorometer. (D and F) Flow cytometric
analysis for LC3B. (D) Bacterial cells were treated with thiourea (200 mM) or deferoxamine (DFO, 10 mM) for 1 hr, then subjected to preparation of BKS-INH. (F)
BMDMswere pretreatedwith NAC (5, 10mM), DPI (5, 10 mM), or tiron (5, 10mM) for 1 hr. Cells were then incubatedwith or without BKS-INH (1%v/v) for 24 hr. The
cells were analyzed for LC3B by flow cytometry. (D and F, right) The average MFI. (F, left) Representative histogram of seven independent replicates. (E) BMDMs
were incubated with BKS-INH (1% v/v) for 30 min, and then the production of superoxide (DHE; 10 mM), hydrogen peroxide (DCFH-DA; 10 mM), or mitochondrial
ROS (MitoSOX; 10 mM) was assayed by flow cytometry. (Top) Representative histogram of seven independent replicates. (Bottom) Data are presented as the
average MFI. (G) BMDMs from NOX2 WT or KO mice were incubated with or without BKS antibiotics (BKS-INH or BKS-PZA; 1% v/v) for 24 hr. Induction of
autophagy was assessed as described in Figure 1A. Data represent the number of LC3+ punctate foci per cell. Data are from one representative of at least three
independent experiments (means ±SD of triplicate [A, bottom; B–D and E, bottom; F, right; G] samples). *p < 0.05, **p < 0.01, ***p < 0.001 (two-tailed Student’s t
test; D and F right, versus SC). UI, uninfected; SC, solvent control (0.1% DMSO). See also Figure S4.
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Antibiotics-Induced Autophagy against MycobacteriaINH significantly reduced the viability of Mtb, and this was
partly reversed by treatment with the autophagy inhibitors
3-MA and wortmannin, as shown by a colony-forming unit
(CFU) assay (Figure 6A). In addition, blocking autophagy by
transduction of human monocyte-derived macrophages
(MDMs) with shBeclin-1 or shAtg5 (lentiviral shRNA specific to
Beclin-1 or Atg5; Yuk et al., 2009) significantly inhibited antimy-
cobacterial activity against Mtb infection, compared to trans-
duction with nonspecific shRNA (Figure 6B). Importantly, INH
treatment did not result in an effective antimicrobial response
in Mtb-infected MDMs transduced with shBeclin-1 or shAtg5
(Figure 6B). We next measured the intracellular antimicrobial
activities in WT or NOX2-deficient BMDMs after INH treatment.
As shown in Figure 6C, NOX2-deficient BMDMs had significantly
attenuated antimycobacterial activity compared to WT BMDMs.462 Cell Host & Microbe 11, 457–468, May 17, 2012 ª2012 Elsevier IWhen cells were treated with INH, the WT BMDMs showed
significantly increased antimicrobial activity against Mtb infec-
tion, whereas the NOX2-deficient BMDMs showed only partial
antimicrobial activity against Mtb infection (Figure 6C).
Drosophila melanogaster is a common in vivo model used to
study innate immunity (Lemaitre et al., 1996) and mycobacterial
infection (Dionne et al., 2003). Moreover, it is currently used as
an alternative model host for the study and discovery of antimi-
crobial compounds (Chamilos et al., 2011). We developed a
mycobacterial infection model using D. melanogaster to study
autophagy in antibiotic-induced host resistance in vivo during
Mm infection. In previous studies, atg7mutants were fully viable
but were hypersensitive to stressors and aging (Juha´sz et al.,
2007). We first evaluated the survival of control and atg7mutants
after complete starvation. Compared to control flies, atg7nc.
Figure 5. Antibiotic-Induced Autophagy Is Medi-
ated through Ca2+- and AMPK-Dependent Path-
ways in Mtb-Infected Macrophages
(A) BMDMs were infected with Mtb (moi = 10) for 2 hr and
incubated with or without INH (0.5 mg/ml), PZA (20 mg/ml),
chloramphenicol (CAM; 10 mg/ml), or tetracycline (Tet;
10 mg/ml) for 5 min. The cells were loaded with Fluo-4/AM
and imaged by confocal microscopy. (Left) Representative
confocal images. Scale bar, 20 mm. (Right) The average
MFI.
(B) BMDMs were loaded with Fura-2/AM, incubated with
or without BKS-INH (1% v/v), and imaged in 5 s intervals
using a Nikon Eclipse microscope. Data show represen-
tative image ratios.
(C–E) Number of LC3+ punctate foci per cell. (C) BMDMs
were infected with Mtb (moi = 1) for 2 hr, followed by
treatment with or without BAPTA/AM (10 mM; 1 hr) or
Compound C (Comp C; 10 mM; 1 hr), and then incubated
with INH (0.5 mg/ml) for 24 hr. (D and E) BMDMs were
transduced with shNS or shAMPK for 3 days. (D) After
lentiviral transduction, cells were infected with Mtb (moi =
10; 2 hr), followed by incubation with or without INH
(0.5 mg/ml) or PZA (20 mg/ml) for 24 hr. (E) Cells were
incubated with BKS-PBS, BKS-INH, or BKS-PZA (1% v/v
for each) for 24 hr. Induction of autophagy was assessed
by confocal analysis, as described in Figure 1A. (D, inset)
RT-PCR analysis of transduction efficiency.
Data are from one representative of at least three inde-
pendent experiments (means ±SD of triplicate [A right,
C–E] samples). *p < 0.05, **p < 0.01, ***p < 0.001 (two-
tailed Student’s t test). UI, uninfected; PBS, PBS treated.
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Antibiotics-Induced Autophagy against Mycobacteriamutants showed increased lethality by starvation (data not
shown), which is consistent with previous reports (Juha´sz
et al., 2007). We then checked the antibiotic susceptibility of
Mm infection in flies and found that either amikacin or rifampicin
exhibited bactericidal effects (data not shown). Notably, the
punctate form of GFP-atg8a was considerably increased in the
fat body of GFP-atg8a larvae administered food with amikacin
or rifampicin after Mm infection or in starvation condition (Fig-
ure S5A and data not shown). However, the punctate form was
not observed in PBS-injected flies, noninjected amikacin- or
rifampicin-fed flies, or Mm-injected flies (Figure S5A and data
not shown). Furthermore, the markedly increased colocalization
of GFP-atg8a with lysosome was observed in the fat body from
GFP-atg8a larvae when fed foodwith amikacin or rifampicin after
Mm infection (Figure 6D). This colocalization was not detected in
PBS-injected flies, uninjected amikacin- or rifampicin-fed flies,
or Mm-injected flies (Figure 6D and data not shown).
We next injected control and atg7 mutant flies with Mm and
monitored survival for 30 days. The atg7mutant flies succumbed
rapidly to Mm challenge, compared to control flies (Figure 6E,
Figure S5B). Control flies administered food containing amikacin
or rifampicin showed significantly increased survival after MmCell Host & Microbe 11injection (Figure 6E, Figure S5B). A similarly
increased, but not complete, protective effect
was observed in atg7 mutant flies after Mm
infection (Figure 6E, Figure S5B). Viable bacte-
rial counts in surviving atg7mutant flies infected
with Mm were consistently higher than those in
control flies infected with Mm (after 3 days; n =30 per group; Figure 6F, Figure S5C). It is important to note
that antibiotic treatment of atg7 mutant flies did not decrease
bacterial loads to the levels observed in antibiotic-treated control
flies (Figure 6F, Figure S5C). The increased sensitivity to Mm
infection was not due to our experimental procedures, as w1118
flies injected with Mm showed increased susceptibility to Mm
in a CFU-dependent manner (Figure S5D). Injection ofw1118 flies
with sterile PBS did not result in significant lethality (Figure S5D).
These findings suggest that host autophagy activation contrib-
utes to and/or is required for the full antimicrobial activities
against intracellular mycobacteria.
Host Cell Autophagy Activation Is Required for the
Regulation of Proinflammatory Cytokine Generation
during Antibiotic Treatment of Mtb-Infected
Macrophages
Autophagy is required to control inflammatory responses (Cad-
well et al., 2009; Saitoh et al., 2008). Thus, we questioned
whether antibiotic-induced autophagy in Mtb-infected cells
may play a role in inflammatory responses. We first investigated
the kinetics of proinflammatory cytokine mRNA and protein
expression in BMDMs after Mtb infection, with and without, 457–468, May 17, 2012 ª2012 Elsevier Inc. 463
Figure 6. Autophagy Contributes to Successful Antimicrobial Responses against Mycobacteria during Antibiotic Treatment
(A–C) Intracellular survival of Mtb assessed by a CFU assay. (A) BMDMs were infected with Mtb (moi = 1) for 2 hr, followed by treatment with 3-MA (3MA, 10 mM;
2 hr) or wortmannin (WM, 100 nM; 1 hr). (B) MDMswere transducedwith nonspecific short-hairpin (shNS) RNA, shAtg5, or shBeclin-1 (shBec1) for 3 days and then
infected with Mtb (moi = 1). (C) BMDMs from NOX2 WT or KO mice were infected with Mtb (moi = 1) for 2 hr. The cells of (A–C) condition were then washed to
remove extracellular bacteria and treated with INH (0.5 mg/ml) for 3 days. Thereafter, intracellular bacteria were harvested, and their viability was assessed using
a CFU assay. The CFU data are the means ±SD of four (A and C) and nine (B) individual experiments.
(D) All panels depict the fat body tissues of fly larvae 4 hr after injection withM.marinum (Mm; 500 CFU). GFP-Atg8a third-instar larvae were infected withMm and
then incubated with or without rifampicin (RFP; 1 mg/ml) or amikacin (AMK; 1 mg/ml). As a starvation control, larvae were transferred to 20% sucrose solution for
4 hr before dissection. The detailed experimental procedure is described in the Experimental Procedures. (Left) Representative images of three independent
experiments are shown. Scale bar, 25 mm. (Right) Quantitative analysis of colocalization between Atg8a and the lysosome. Bar graph showing coefficient factors
(R2). Genotype, Cg-GAL4, UAS-GFP-ATG8a/+. Data are from one representative of at least three independent experiments (means ±SD of triplicate samples).
(E and F) Control and atg7 mutant flies were injected with 500 CFU Mm and then maintained with or without AMK (1 mg/ml). (E) Dead flies were counted in
24 hr intervals. The error bars indicate 95% confidence intervals. Log-rank analysis of the survival curves indicated that each condition was significantly different
(***p < 0.001) on day 30. n = 120 for each condition. (F) After 3 days, each group of flies was homogenized, harvested, and quantified using a CFU assay. The
experiments were repeated three times.
N.S., no significant; **p < 0.01, ***p < 0.001 (two-tailed Student’s t test; B, versus shNS-transduced, INH-treated condition; C, versus PBS-treated condition;
D, versus Mm-infected condition). UI, uninfected; PBS, PBS treated. See also Figure S5.
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(TNF)-a, interleukin (IL)-6, and IL-1b was significantly increased
in BMDMs at different time points from 3 to 12 hr after infection
with Mtb, and INH treatment did not augment the Mtb-induced
mRNA expression of proinflammatory cytokines in BMDMs
(Figure 7A). In addition, the secretion of TNF-a, IL-6, and IL-1b
was lower in Mtb-infected BMDMs after treatment with INH
than in Mtb-infected BMDMs that were not treated with INH
(Figure S6A).
To further characterize the role of autophagy in modulating
inflammatory cytokine generation in Mtb-infected macrophages464 Cell Host & Microbe 11, 457–468, May 17, 2012 ª2012 Elsevier Iafter antibiotic treatment, Mtb-infected BMDMs were treated
with 3-MA or wortmannin, two inhibitors of phosphoinositide
3-kinase (class III PI3K, which is required for the activation of au-
tophagy) (Gutierrez et al., 2004), or MDMs were transfected with
shBeclin-1 or shAtg5 prior toMtb infection, followed by antibiotic
treatment. Mtb/INH-induced production of TNF-a, IL-6, and
IL-1b was significantly increased in BMDMs or MDMs treated
with 3-MA or wortmannin (Figure 7B). Similarly, primary MDMs
transduced with shBeclin-1 or shAtg5 exhibited significantly
increased Mtb/INH-induced production of TNF-a and IL-6 (Fig-
ure 7C). We further examined whether BKS antibiotic-inducednc.
Figure 7. INH-Induced Autophagy Negatively
Regulates Mtb-Induced Proinflammatory Cytokine
Production in Mtb-Infected Macrophages
(A) BMDMs were infected with Mtb (moi = 10) for 2 hr,
incubated with INH (0.5 mg/ml) for the indicated times, and
subjected to semiquantitative RT-PCR analysis for TNF-a,
IL-6, IL-1b, and b-actin.
(B) BMDMs (left) or MDMs (right) were infected with Mtb
(moi = 10) for 2 hr, followed by treatment with 3-MA
(10 mM; 2 hr) or wortmannin (WM, 100 nM; 1 hr), and then
incubated with INH (0.5 mg/ml) for 24 hr. Supernatants
were collected and subjected to ELISA for assessment of
TNF-a, IL-6, and IL-1b production.
(C) MDMs were transduced with shNS, shAtg5, or
shBeclin-1 (shBec1) for 3 days. After transduction, cells
were infected with Mtb (moi = 10) and incubated with or
without INH (0.5 mg/ml). Supernatants were collected 24 hr
after INH treatment and subjected to ELISA for TNF-a and
IL-6. (Inset) RT-PCR analysis was performed to assess
transduction efficiency.
Data are from one representative of at least three inde-
pendent experiments (means ±SD of triplicate [B and C]
samples). ***p < 0.001 (two-tailed Student’s t test). UI,
uninfected; SC, solvent control (0.1% DMSO). See also
Figure S6.
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macrophages. Blockade of autophagy pathways by the inhibi-
tors significantly increased the BKS-INH- or BKS-PZA-induced
generation of TNF-a and IL-6 in BMDMs (Figures S6B and
S6C). Thus, activation of autophagy by antibiotics contributed
to the control of inflammatory responses, suggesting a negative
role for autophagy in Mtb-induced inflammatory responses in
macrophages.
DISCUSSION
Several drugs can activate or inhibit the autophagy process.
Rapamycin induces autophagy through inhibition of the target
of rapamycin (TOR) pathway (Deretic, 2010; Jo, 2010). Antitumor
DNA-damaging drugs, including doxorubicin and melphalan,
trigger Beclin 1-regulated autophagy in tumor cell lines (Pan
et al., 2011). On the other hand, clarithromycin attenuates au-
tophagy in myeloma cells to exert anticancer effects (Nakamura
et al., 2010). However, it is not known whether autophagy is
activated and/or whether it plays a role in host defenses during
chemotherapy. Our data suggest amechanism by which antimy-
cobacterial drugs activate autophagy pathways to control intra-
cellular mycobacterial infection. On the basis of our findings, we
propose the following integrated model whereby antibiotics
trigger autophagy activation through bacterial and cellular ROS
generation (Figure S7).
Here, we present three lines of evidence supporting the
conclusion that the activation of autophagy in host cells is
strongly associated with, or required for, antimicrobial activities
of drugs used to treat intracellular mycobacteria. First, it is
noteworthy that autophagy was activated at time points earlier
than those at which drug antimicrobial activities were achieved.
Antibiotic-induced autophagosome formation and its fusion with
the mycobacterial phagosome were usually observed in cellsCell Hwithin 24 hr, and significant antimicrobial activities were followed
by 3 days of infection. Second, INH- or PZA-resistant strains did
not induce autophagy activation or ROS generation in drug-
treated macrophages. Third, autophagy-defective flies showed
increased bacterial loads in vivo and decreased survival after
infection. Antibiotic treatment did not effectively protect autoph-
agy-defective flies against Mm infection, compared to WT flies.
Together, these data strongly suggest that autophagy, which
can be triggered and modulated by bacterial and cellular ROS,
is required for antimicrobial activities against mycobacterial
infection during chemotherapy. Nonetheless, there is a possi-
bility that two drug-induced mechanisms, namely autophagy
activation and direct killing effects, may contribute to macro-
phage control of infection cooperatively and/or in parallel.
Importantly, treatment of Mtb-infected macrophages with INH
or PZA resulted in colocalization of the LC3 autophagosome and
bacterial phagosome. This strongly suggests that antibiotic-
induced autophagy targets bacteria to progressively more acidic
compartments, eventually destined for lysosomal degradation.
Moreover, our data are important in that they represent the first
step toward unraveling the mechanism of action of PZA inside
cells and in vivo. PZA is a prodrug of the active agent pyrazinoic
acid (POA), converted into POA by nicotinamidase/pyrazinami-
dase of Mtb (Zhang and Mitchison, 2003). There has until now
been a paradox in that PZA shows strong in vivo sterilizing
activity against Mtb but is activated in acidic environments (pH
5.0–5.5) in vitro (McDermott and Tompsett, 1954). Notably,
PZA treatment of macrophages cultured in normal conditions
at neutral pH can induce autophagy and reduce intracellular
bacterial growth (see Figure 2). Previous studies (Huynh and
Grinstein, 2007) showed that phagosomal pH (6.3–6.5) is
slightly lower than cytoplasmic pH (7.0–7.2) after Mtb infection.
We found that PZA treatment significantly induces the produc-
tion of hydroxyl radicals and ROS in bacterial cells under slightlyost & Microbe 11, 457–468, May 17, 2012 ª2012 Elsevier Inc. 465
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upregulation of bacterial hydroxyl radicals may trigger an initi-
ating mechanism of autophagy activation leading to the acidifi-
cation of bacterial phagosomes (phagosomal maturation) and
drug antimicrobial activities by PZA during Mtb infection.
Themode of action of antibiotics can be classified on the basis
of their drug-target interaction. However, it is interesting that the
major classes of bactericidal antibiotics, regardless of drug-
target interaction, exert their effects through the generation of
highly deleterious hydroxyl radicals in both Gram-negative and
Gram-positive bacteria (Kohanski et al., 2007, 2008). Our data
emphasize that drug-induced pathways involving both bacterial
and cellular ROS generation can activate host cell autophagy,
which contributes to antimicrobial responses. ROS release
during chemotherapy has been observed in both TB patients
and experimental studies. Using allantoin as an ROS marker,
a combination of antibiotics (INH, rifampin, and PZA) significantly
enhanced plasma allantoin in TB patients (Walubo et al., 1995).
One study using an animal model indicated that INH and rifampin
induce a significant respiratory burst involving NADPH oxidase
and nitric oxide synthesis (Sharma et al., 2007). ROS are impli-
cated in the bactericidal activities of anti-TB drugs in vivo
(Mitchison and Selkon, 1956; Youatt, 1969). Moreover, elevated
oxidative stress responses are thought to explain the intrinsic
sensitivity of Mtb to INH (Deretic et al., 1996). Thus, it is possible
that ROS generation is induced by anti-TB drug therapy during
TB infection.
Recent studies have provided evidence that ROS are essential
signaling messengers in the initiation of autophagy as well as
various other intracellular processes (Azad et al., 2009; Scherz-
Shouval and Elazar, 2011). NOX-derived ROS participate in
autophagy responses to Toll-like receptors and Fcg receptors
during phagocytosis (Huang et al., 2009). Our previous study
revealed the role of cellular and mitochondrial ROS in the activa-
tion of autophagy in macrophages infected with enhanced
intracellular survival (eis) gene-deficient mycobacteria (Shin
et al., 2010b). Mitochondrial ROS also contribute to the antibac-
terial response by interacting with tumor necrosis factor
receptor-associated factor 6 (TRAF6) and evolutionarily con-
served signaling intermediate in Toll pathways (ECSIT) (West
et al., 2011). Additionally, intracellular calcium influx and AMPK
pathway significantly influenced the activation of autophagy
process in Mtb-infected macrophages after treatment with
anti-TB drugs. These observations partly corroborate our pre-
vious findings that vitamin D-induced autophagy activation
was regulated by intracellular Ca2+- and AMPK-dependent
pathways (Yuk et al., 2009). A variety of intracellular calcium-
mobilizing agents, including thapsigargin, ATP, and ionomycin,
may also trigger the AMPK pathway through activation of
Ca2+/calmodulin-dependent kinase kinase-b, which is required
for Ca2+-induced autophagy (Hoyer-Hansen et al., 2007;
Hoyer-Hansen and Ja¨a¨ttela¨, 2007). Together, increased ROS
generation and the calcium-dependent AMPKmay play a central
role in antibacterial effects through autophagy-dependent and
independent pathways during antibiotic treatment of Mtb
infection.
Our results reveal a role for antibiotic-induced autophagy in
the antimicrobial effects of chemotherapy against Mtb infection.
We also observed that blockade of autophagy does not affect466 Cell Host & Microbe 11, 457–468, May 17, 2012 ª2012 Elsevier Iintracellular growth of Mtb possessing a katG or a pncAmutation
in cells treated with antibiotics (data not shown). The roles
of antibiotic-induced autophagy in controlling antimicrobial
responses during mycobacterial infection have been difficult to
demonstrate directly using the atg-defective murine system
in vivo. Using aDrosophilamodel host system, we demonstrated
that autophagy activation is essential for the antimicrobial
effect against mycobacteria in adult flies. By inhibiting the
autophagy process in vivo using RNAi against components of
the autophagic machinery, we showed that inhibition of autoph-
agy decreased the survival of flies, reflecting exacerbated
infection. Moreover, atg7 mutant flies had defective antibiotic
responses during Mm infection, compared to control flies.
Thus, the current data strongly suggest that host autophagy
activation is critically involved in successful host responses
during antibiotic treatment in vivo.
Blocking autophagy during antibiotic treatment significantly
enhanced the inflammatory response in murine and human
macrophages, suggesting that host autophagy activation is
required for homeostatic control during chemotherapy against
intracellular Mtb infection. Recent studies have shown that au-
tophagy plays a role in regulating the inflammatory response
and the inflammasome to prevent excessive inflammation (Levine
et al., 2011; Nakahira et al., 2011). Previous data and this
study indicate that autophagy activation is critical for controlling
inflammatory responses through modulation of cellular and mito-
chondrial ROS production (Mathew et al., 2009; Lee et al., 2011;
Nakahira et al., 2011). This suggests that autophagic elimination
of harmful intracellular materials is required to prevent inflamma-
tion and unwanted tissue damage. The present data suggest
that autophagy plays a role in host protective responses during
antibiotic therapy against Mtb infection by maintaining a balance
between the innateantimicrobial andproinflammatory responses.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Mice, Cells, and Reagents
All mycobacteria were grown in 7H9 medium supplemented with 0.5% glyc-
erol, 0.5% Tween-80 (Sigma, St. Louis, MO, USA), and 10% oleic acid,
albumin, dextrose, and catalase (OADC; BD Biosciences, San Jose, CA,
USA). Mice used as a source of cells for in vitro experiments were housed
under specific pathogen-free conditions. All animal procedures were con-
ducted in accordance with the guidelines of the Institutional Animal Care
and Use Committee, Chungnam National University. Primary BMDMs, human
primary monocytes, and MDMs were prepared as described previously (Yuk
et al., 2009). Details of the bacteria, mice, cells, and reagents are provided
in the Supplemental Information.
Autophagy Analysis
Autophagosome formation was measured by LC3 punctate staining, as
described previously (Yuk et al., 2009). To quantitate autophagy, we used
fluorescence microscopy to count the number of endogenous LC3 punctate
dots in primary cells using the ImageJ analysis software. Each condition was
assayed in triplicate, and at least 200 cells per well were counted. LC3-II
protein levels were evaluated by western blot analysis using an antibody
against LC3 (Novus Biologicals, Littleton, CO, USA). As positive controls for
the autophagy induction experiments, cells were starved by washing three
times with PBS and incubating in HBSS for 2 hr at 37C.
Preparation of BKS Antibiotics
To prepare supernatants from bacteria killed by INH (BKS-INH) or PZA
(BKS-PZA), Mtb suspension (containing 1 3 108 CFU) was incubated withnc.
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Antibiotics-Induced Autophagy against MycobacteriaINH (0.5 mg/ml) or PZA (20 mg/ml) for various amounts of time under pH 5.5
(for PZA). The supernatants (BKS-INH or BKS-PZA) were collected after centri-
fugation at 20,0003 g for 20 min. For treatment with BKS antibiotics, BMDMs
were incubated with 1% (v/v) of the collected supernatants.
Fly Culture, M. marinum Infection, Autophagy Detection, and
Quantification of Autolysosomes in Drosophila
Flies were maintained on standard cornmeal medium at 25C and 80%
humidity. w1118 and Cg-GAL4 were obtained from the Bloomington Stock
Center. UAS-GFP-Atg8a (Juha´sz et al., 2008), Atg7d14, Atg7d77, and
CG5335d30 (Juha´sz et al., 2007) were kindly provided by the Neufeld group.
For the autophagy detection, Cg-GAL4,UAS-GFP-ATG8a/+ third-instar
larvae were isolated and infected with 500 CFU of Mm by direct injection. In-
fected larvaewere transferred to standard cornmeal medium or antibiotic-con-
taining medium (1 mg/ml amikacin or 1 mg/ml rifampicin) and then incubated at
25C and 80% humidity for 4 hr. As a starvation control, larvae were trans-
ferred to 20% sucrose solution for 4 hr before dissection. Larvae were
dissected and inverted in PBS. The fat body from each carcass was fixed over-
night at 4C in 4% paraformaldehyde/PBS, washed extensively in PBS, and
mounted with Vectashield (Vectorlabs, Burlingame, CA).
For analysis of autolysosomes in Drosophila, fat bodies from fed or starved
larvae were dissected in PBS, incubated in LysoTracker Red DND-99 (1 mM;
Molecular Probes, Eugene, OR, USA) and DAPI in PBS for 2 min, transferred
to glass slides, coverslipped, and immediately photographed under an
Olympus IX81 confocal microscope. Quantitative analysis of coefficient
factors was performed using the software FV1000 viewer (version 3.0,
Olympus).
Miscellaneous Procedures
Details of western blotting, RT-PCR, sandwich ELISAs, electron microscopy,
immunofluorescence, confocal analysis, measurements of ROS and intracel-
lular Ca2+, lentiviral shRNA generation and transduction into primary cells,
and mycobacterial infection and bacterial counts are provided in the Supple-
mental Information.SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, Supplemental Experimental
Procedures, and Supplemental References and can be found at doi:10.1016/
j.chom.2012.03.008.
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